| Catalog_no |
ADMC0292 |
| Product_name |
R306465(JNJ-16241199) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
2340.00/8340.00/13880.00 |
| Specificity |
Target: See reference. Fields: R306465, also known as JNJ-16241199, is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models. |
| Dilution |
|
| Purification |
97% |
| Concentration |
靶点：See reference;IC50：No data |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
R 306465,JNJ16241199,R-306465,JNJ 16241199 |
| Molecular Weight |
413.11 |
| Notes |
R306465, also known as JNJ-16241199, is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models. |
| Instructions |
 查看与下载 |
